5012 V (Phenobarbital 32.4 mg)
Pill imprint 5012 V has been identified as Phenobarbital 32.4 mg.
Phenobarbital is used in the treatment of seizures; sedation; hyperbilirubinemia; insomnia and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Phenobarbital 32.4 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- 5012 V
- 32.4 mg
- Prescription only
- Drug Class:
- Barbiturate anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Qualitest Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|63739-0201||McKesson Packaging Services|
|68084-0814||Amerisource Health Services|
|67544-0057||Prepak Systems Inc (repackager)|
|55289-0535||PDRX Pharmaceuticals Inc (repackager)|
More about phenobarbital
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 14 Reviews – Add your own review/rating
- Drug class: barbiturate anticonvulsants
Other brands: Luminal
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.